Compare Vir Biotechnology Inc. Common Stock (VIR) vs Vanguard Total Stock Market Index Fund ETF (VTI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vir Biotechnology Inc. Common Stock vs Vanguard Total Stock Market Index Fund ETF — how do they compare? Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B), while Vanguard Total Stock Market Index Fund ETF trades at $375.68 (market cap $2.30T). The key difference: Vanguard Total Stock Market Index Fund ETF is far larger — about 1277.8× Vir Biotechnology Inc. Common Stock's market cap, and Vanguard Total Stock Market Index Fund ETF is trading nearer its 52-week high, Vir Biotechnology Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Vir Biotechnology Inc. Common Stock for 0 Days and Vanguard Total Stock Market Index Fund ETF for 132 Days on average.
| VIR | VTI | |
|---|---|---|
Market Cap | $1.80B | $2.30T |
Volume | 1,782,836 | 2,460,185 |
Sector | Health | — |
52-Week High | $11.78 | $384.30 |
52-Week Low | $5.12 | $311.68 |
Typical Hold Time | 0 Days | 132 Days |
Enterprise Value | $1.36B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VTI trades at $381.32, down slightly by 0.07% today, with a bullish technical signal driven by strong moving average alignment. The ETF offers broad U.S. equity exposure, though key financial ratios are not provided in the data. Recent news highlights its appeal for long-term investors seeking diversification and low-cost market access.
The outlook remains positive given strong technical momentum and media optimism, but risks include market concentration in top holdings and broader economic volatility. Investors benefit from VTI's extensive diversification, yet should monitor allocation weights and macroeconomic trends for potential impacts on returns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →About Vanguard Total Stock Market Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the index, which represents approximately 100% of the investable US stock market and includes large-, mid-, small-, and micro-cap stocks. It invests by sampling the index, meaning that it holds a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.
Read more on VTI →
